David García

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 11 papers. Top paper: “Apixaban versus Warfarin in Patients with Atrial Fibrillation”.

Apixaban versus Warfarin in Patients with Atrial Fibrillation

New England Journal of Medicine(2011)10.1056/nejmoa1107039

N/A

1.4DataRank · unranked

8849 citations

John H. Alexander, John J.V. McMurray, Renato D. Lopes, Elaine M. Hylek, Michael Hanna +37 more

Risks factors and outcomes for isolated catheter-related deep venous thrombosis in patients undergoing allogeneic hematopoietic stem cell transplantation

Thrombosis Research(2023)10.1016/j.thromres.2023.06.017

N/A

0.385DataRank · unranked

12 citations

Danielle Guffey, Shengling Ma, Ryan Basom, Stephanie J. Lee, David García +4 more

A systematic review of the association between anti-β-2 glycoprotein I antibodies and APS manifestations

Blood Advances(2021)10.1182/bloodadvances.2021005205

N/A

0DataRank · unranked

31 citations

Wendy Lim, Mark Crowther, David García, Debbie Jiang

Direct Oral Anticoagulants vs Vitamin K Antagonists in Patients With Antiphospholipid Syndromes

Journal of the American College of Cardiology(2022)10.1016/j.jacc.2022.10.008

N/A

0DataRank · unranked

159 citations

Antoine Bejjani, Gregory Piazza, David Jiménez, Manuel Monréal, Saurav Chatterjee +13 more

Derivation and Validation of a Clinical Risk Assessment Model for Cancer-Associated Thrombosis in Two Unique US Health Care Systems

Journal of Clinical Oncology(2023)10.1200/jco.22.01542

N/A

0DataRank · unranked

72 citations

Jennifer La, Sarah May, Danielle Guffey, Wilson Luiz da Costa, Christopher I. Amos +16 more

Development and validation of a risk model for hospital-acquired venous thrombosis: the Medical Inpatients Thrombosis and Hemostasis study

Journal of Thrombosis and Haemostasis(2023)10.1016/j.jtha.2023.10.015

N/A

0DataRank · unranked

13 citations

Katherine Wilkinson, Andrew Sparks, Ryan T. Packer, Insu Koh, Nicholas S. Roetker +18 more

“Autoimmune HIT” antibodies in diagnostic samples are a potential artifact and not associated with more severe outcomes

Blood Advances(2023)10.1182/bloodadvances.2023009811

N/A

0DataRank · unranked

3 citations

Janhavi Athale, Rachel Leger, A Saadalla, Nahla Heikal, Dong Chen +5 more

Development and validation of risk models for hospital-acquired bleeding in medical inpatients: the Medical Inpatients Thrombosis and Hemostasis (MITH) study

Journal of Thrombosis and Haemostasis(2025)10.1016/j.jtha.2025.07.007

N/A

0DataRank · unranked

2 citations

Katherine Wilkinson, Andrew Sparks, Ryan T. Packer, Nicholas S. Roetker, Allen B Repp +19 more

Clinical Factors Associated With Catheter‐Related VTE in Patients Undergoing Hematopoietic Cell Transplantation: A Multi‐Center Study

American Journal of Hematology(2025)10.1002/ajh.27720

N/A

0DataRank · unranked

1 citations

Danielle Guffey, Jonathan Avery, David García, Ryan Basom, Stephanie J. Lee +9 more

Development of the 2023 ACR / EULAR Antiphospholipid Syndrome Classification Criteria, Phase III ‐C Report: Assessment of Patient Scenarios (Derivation Cohort) and Refinement of Definitions

Arthritis Care & Research(2025)10.1002/acr.25599

N/A

0DataRank · unranked

1 citations

Stéphane Zuily, Deanna Jannat‐Khah, Mary‐Carmen Amigo, Danieli Andrade, Tadej Avčin +26 more

Development of a New International Antiphospholipid Syndrome Classification Criteria Phase I/II Report: Generation and Reduction of Candidate Criteria

Arthritis Care & Research(2020)10.1002/acr.24520

N/A

0DataRank · unranked

91 citations

Stéphane Zuily, Yasaman Ahmadzadeh, Mary‐Carmen Amigo, Tadej Avčin, María Laura Bertolaccini +19 more